Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Allergy Asthma Immunol. 2013 Apr;110(4):228-32. doi: 10.1016/j.anai.2012.12.010. Epub 2013 Jan 5.

Mechanisms of disease for the clinician: systemic lupus erythematosus.

Author information

1
Department of Medicine, Nassau University Medical Center, an affiliate of North Shore Long Island Jewish (NSLIJ) Health Care System, and Department of Medicine and Pathology, The State University of New York, Stony Brook, New York, 11554, USA. mfrieri@numc.edu.

Abstract

OBJECTIVE:

To review the complex interactions and processes in systemic lupus erythematosus (SLE).

DATA SOURCES:

Brief review of the important literature in peer-reviewed journals.

STUDY SELECTION:

Studies on the clinical and immunologic features, pathogenesis, epidemiology, laboratory evaluation, and treatment of SLE are included in this review.

RESULTS:

SLE may include a variety of disease entities, such as isolated cutaneous lupus, undifferentiated connective tissue disease, mixed connective tissue disease, and drug-induced lupus. There are many ongoing clinical trials in SLE patients of therapeutics with different mechanisms of cellular action, such as classic immunosuppression, cell depletion, antigen-specific immunomodulation, and targeting of antigen-nonspecific, immune-activating molecules. New immune cell-targeted therapies are now available that are specifically designed to block cellular pathways involved in disease pathogenesis.

CONCLUSION:

The practicing physician should understand the immunology, pathogenesis, laboratory evaluation, and updated treatment options when diagnosing SLE in their clinic or daily practice.

PMID:
23535084
DOI:
10.1016/j.anai.2012.12.010
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center